Usamos cookies propias y de terceros para mejorar tu experiencia de navegación, y ofrecerte contenidos y publicidad relevantes para ti.
Our top-notch facilities manufacture solid and semi-solid products. Aware of the huge importance of keeping the specificities of each partner in mind, we work non-stop to provide a fine service that makes us reactive, flexible and competitive.
We adapt to all our customers, giving them personalised attention and adjusting our processes to meet their needs.
The plant is equipped to manufacture high-quality tablets, capsules, pills, film-coated tablets, effervescent tablets, granules, powders, creams and ointments.
Our focus on customers shortens lead times while our operational excellence keeps costs down.
Our approach consists of providing top-notch service in terms of quality, trust and cost through a partnership scheme in which we look for solutions to our customers' specific needs with a high degree of flexibility and adaptability.
Manufacture of proprietary drugs
Right next to the pharmaceutical plant stands our food supplements manufacturing plant. It makes the vast majority of food supplements —currently about 50— for the Consumer Health division.
We offer end-to-end service for the production of Food Supplements in keeping with the general lines of the services provided at the pharmaceutical plant.
At Urquima we develop and produce both NCEs (i.e. triflusal, rupatadine, flutrimazole, cimicoxib) and generic APIs such as glipizide, ropinirole and glimepiride, among others.
Some of these products are in regular production runs, whereas others are at an advanced stage of development or industrialisation.
The chemical plant has 120 m3 of reaction capacity. It is a multi-product factory that manufactures about 50 tonnes of active ingredients every year.